| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f312cc7676e939dee48fb4fdfe921ce8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d03998e5779127c913bef69015b7ee92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e30ae7e69538cd39c564599799f62e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70be61867e30529c292645a11465dc47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_050b5c881b3136e8ebd8bbe606611a63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_418d388bb58640a0d76faab369fc4270 |
| publicationDate |
2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113018303-A |
| titleOfInvention |
Application of Tanshinone IIA Sulfonate Sodium Injection in the Preparation of Antiviral Drugs |
| abstract |
The invention discloses the application of tanshinone IIA sodium sulfonate injection in the preparation of antiviral medicines. The present invention proposes the application of tanshinone IIA sodium sulfonate injection in the preparation of antiviral drugs for the first time, and provides a new treatment method for patients with new coronary infection with chronic underlying diseases, and the application expands the clinical application range of tanshinone IIA sodium sulfonate injection. , and for viral suppression, especially in the context of the global SARS-CoV-2 epidemic, to provide new drugs for the treatment of pneumonia caused by new coronavirus infection (COVID-19). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4119145-A1 |
| priorityDate |
2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |